These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1281122)

  • 1. [Change in serum G-CSF levels in patients with Graves' disease by treatment with methimazole].
    Hara H; Ban Y; Sato R; Ishikawa N; Yoshimura H; Hisaoka T; Ito K
    Nihon Naibunpi Gakkai Zasshi; 1992 Oct; 68(10):1121-9. PubMed ID: 1281122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum granulocyte colony-stimulating factor levels in patients with Graves' disease.
    Iitaka M; Noh JY; Kitahama S; Fukasawa N; Miura S; Kawakami Y; Kawasaki S; Yamanaka K; Ishii J; Katayama S; Ito K
    Clin Endocrinol (Oxf); 1998 Mar; 48(3):275-80. PubMed ID: 9578815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis.
    Murakami Y; Sasaki I; Hiraiwa T; Arishima T; Ito M; Hanafusa T; Sakane S; Ohsawa N; Takamatsu J; Miyauchi A; Kuma K
    Endocr J; 2004 Dec; 51(6):579-85. PubMed ID: 15644577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morning granulocytopenia in a case of Graves' disease.
    Nakamura S; Isaji M; Ishimori M
    Endocr J; 2001 Apr; 48(2):181-4. PubMed ID: 11456265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
    Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
    Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris.
    Miyasaka Y; Yoshimura M; Tabata S; Shozu A; Nishikawa M; Iwasaka T; Inada M
    Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
    Magner JA; Snyder DK
    Thyroid; 1994; 4(3):295-6. PubMed ID: 7530522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methimazole-induced agranulocytosis in Japanese patients with Graves' disease.
    Tamai H; Takaichi Y; Morita T; Komaki G; Matsubayashi S; Kuma K; Walter RM; Kumagai LF; Nagataki S
    Clin Endocrinol (Oxf); 1989 May; 30(5):525-30. PubMed ID: 2605789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia.
    Tajiri J; Noguchi S; Murakami N
    Thyroid; 1997 Aug; 7(4):575-8. PubMed ID: 9292945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
    Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G
    Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
    Schut NH; Wiersinga WM; Van Oers MH
    Neth J Med; 1993 Aug; 43(1-2):71-3. PubMed ID: 8232698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
    Tajiri J; Noguchi S; Okamura S; Morita M; Tamaru M; Murakami N; Niho Y
    Arch Intern Med; 1993 Feb; 153(4):509-14. PubMed ID: 7679571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
    Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF levels during spontaneous recovery from drug-induced agranulocytosis.
    Fukata S; Murakami Y; Kuma K; Sakane S; Ohsawa N; Sugawara M
    Lancet; 1993 Dec; 342(8885):1495. PubMed ID: 7504155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Granulocyte colony-stimulating factor treatment (G-CSF) of antithyroid drug-induced granulocytopenia: granulocyte count measurement after 4 hours of G-CSF injection is useful for the detection of recovery from granulocytopenia].
    Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
    Nihon Naibunpi Gakkai Zasshi; 1994 Jun; 70(5):517-20. PubMed ID: 7525366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor.
    Adorf D; Grajer KH; Kaboth W; Nerl C
    Clin Investig; 1994 May; 72(5):390-2. PubMed ID: 7522068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
    Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
    Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.